Related Experiment Videos
Inhibition of human complement by beta-glycyrrhetinic acid
B H Kroes1, C J Beukelman, A J van den Berg
1Research Centre for Natural Products and Phytopharmaceuticals, Faculty of Pharmacy, University of Utrecht, The Netherlands.
Immunology
|January 1, 1997
Summary
Beta-glycyrrhetinic acid, derived from licorice, potently inhibits the classical complement pathway, a key part of the immune system. This compound
Area of Science:
- Immunology
- Pharmacology
- Natural Products Chemistry
Background:
- Licorice root (Glycyrrhiza glabra L.) is a traditional medicine.
- Glycyrrhizin and its aglycone, beta-glycyrrhetinic acid, possess anti-inflammatory and anti-allergic properties.
- Beta-glycyrrhetinic acid has a steroid-like structure and potential immunomodulatory effects.
Purpose of the Study:
- To investigate the immunomodulatory effects of beta-glycyrrhetinic acid on the human complement system.
- To determine if beta-glycyrrhetinic acid interferes with complement activation pathways.
- To elucidate the mechanism of action and specificity of its anticomplementary activity.
Main Methods:
- In vitro assays were used to assess the effects of beta-glycyrrhetinic acid on the classical and alternative complement pathways.
- Inhibition concentrations (IC50) were determined for both pathways.
- Mechanistic studies focused on the interaction with complement component C2.
- Conformational activity was assessed using the alpha-form of beta-glycyrrhetinic acid.
- Comparison with naturally occurring steroids like hydrocortisone and cortisone was performed.
Main Results:
- Beta-glycyrrhetinic acid is a potent inhibitor of the classical complement pathway with an IC50 of 35 microM.
- No significant inhibition was observed for the alternative complement pathway (IC50 > 2500 microM).
- The anticomplementary activity is conformation-dependent, with the beta-form being active and the alpha-form inactive.
- Naturally occurring steroids did not inhibit complement activity under the same conditions.
- Mechanistic studies indicated that beta-glycyrrhetinic acid targets complement component C2.
Conclusions:
- Beta-glycyrrhetinic acid exhibits potent and specific inhibition of the classical complement pathway.
- Its immunomodulatory activity may be mediated through interference with complement component C2.
- The findings suggest a potential therapeutic role for beta-glycyrrhetinic acid in complement-mediated inflammatory conditions.